ARCHIVES

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

This article is from The Cancer Letter archive.

Vol. 29 No. 40 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

Armstrong Foundation To Fund Studies In Testicular Cancer

April 17, 1998

NIH to Hold Meeting On Faculty Design

February 2, 1996

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

CCOPs Favor Ability To Enter Patients On Any Group Study

June 12, 1998